Record $32B Backlog and Q2 Beat Support Elbit Despite 17% Drop; Pullback Seen as Buy Opportunity

What happened

Since the DeepValue master report's POTENTIAL SELL call at $711, ESLT shares have corrected 17% despite improved fundamentals. Q2 2026 revenue grew 15.9% year-over-year with margin expansion and free cash flow more than doubling, while the order backlog reached a record $32 billion. The decline was likely driven by profit-taking after the stock's meteoric rise and lingering ESG and delivery risk concerns. The Seeking Alpha article argues the pullback is a buying opportunity, citing the backlog's revenue visibility, though capacity constraints cap near-term upside. Overall, the business momentum counters the bear thesis of demand slowdown, but elevated valuation and political risks persist.

Implication

Near term, the record backlog and margin improvements support earnings resilience, but delivery schedules and ESG overhangs may keep the stock range-bound. The 17% correction partially alleviates the valuation stretch flagged in the master report, yet at a still-elevated multiple, further downside is possible if growth moderates. Investors should monitor backlog conversion rates and any resolution of the NSPA tender suspension or new procurement bans. The current price is closer to the attractive entry zone but remains above the $500 level suggested for a high-conviction buy. Until ESG risks ease or the stock nears that floor, a cautious stance is warranted.

Thesis delta

The unprecedented backlog growth to $32B and robust Q2 results challenge the bear case of slumping demand. Nevertheless, the 17% share-price decline substantiates the valuation concerns outlined in the master report, as the market re-prices growth expectations. The improved risk/reward is not yet compelling enough to upgrade from POTENTIAL SELL, given unresolved ESG and capacity constraints.